Company intelligence / Profile preview

Paracelsus

London, England, United Kingdomparacelsus.com ↗

Ownership: Private
Development stage: Commercial

Overview

Paracelsus is a name used by several active companies in life sciences/pharma/healthcare fields globally. These include a US-based nonclinical safety/regulatory consultancy ("Paracelsus, Inc."), a UK/EU-based pharmaceutical firm ("Paracelsus Pharmaceutical"), and a consumer health/lab products firm ("Paracelsus Labs") offering commercial products like CELSUS scar cream. No clinical trial results are publicly disclosed under these names.

Therapeutic areas: OncologyOtherDermatologyRheumatologyInfectious Diseases
Modalities: Topical creamSmall moleculeBiologic
Industry: Biotech

Beyond the preview

Go deeper on Paracelsus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Paracelsus.

Explore the full profile